We are live on
!
Find out more
Ascendis Pharma A/S
ASND
ASND
302 hedge funds and large institutions have $13.8B invested in Ascendis Pharma A/S in 2025 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 121 increasing their positions, 91 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
211% more call options, than puts
Call options by funds: $189M | Put options by funds: $60.8M
68% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 37
33% more repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 91
9% more capital invested
Capital invested by funds: $12.7B → $13.8B (+$1.09B)
8% more funds holding
Funds holding: 279 → 302 (+23)
0.91% more ownership
Funds ownership: 103.53% → 104.44% (+0.91%)
29% less funds holding in top 10
Funds holding in top 10: 17 → 12 (-5)
Holders
302
Holders Change
+23
Holders Change %
+8.24%
% of All Funds
3.67%
Holding in Top 10
12
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-29.41%
% of All Funds
0.15%
New
62
Increased
121
Reduced
91
Closed
37
Calls
$189M
Puts
$60.8M
Net Calls
+$128M
Net Calls Change
+$43.4M
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$206M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$102M |
| 3 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$101M |
| 4 |
VPC
Vestal Point Capital
New York
|
-$87.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$68.5M |
